Chemoinformaics analysis of 8-(3-Ethoxy-2-hydroxy-3-methylbutyloxy)psoralen
| Molecular Weight | 332.352 | nRot | 6 |
| Heavy Atom Molecular Weight | 312.192 | nRig | 16 |
| Exact Molecular Weight | 332.126 | nRing | 3 |
| Solubility: LogS | -3.844 | nHRing | 2 |
| Solubility: LogP | 2.527 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 15 |
| nHA | 6 | APOL | 48.2079 |
| nHD | 1 | BPOL | 27.8761 |
| QED | 0.699 |
| Synth | 3.528 |
| Natural Product Likeliness | 1.542 |
| NR-PPAR-gamma | 0.463 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.034 |
| Pgp-sub | 0.031 |
| HIA | 0.011 |
| CACO-2 | -4.769 |
| MDCK | 0.0000241 |
| BBB | 0.022 |
| PPB | 0.857258 |
| VDSS | 1.247 |
| FU | 0.0905728 |
| CYP1A2-inh | 0.947 |
| CYP1A2-sub | 0.703 |
| CYP2c19-inh | 0.428 |
| CYP2c19-sub | 0.133 |
| CYP2c9-inh | 0.547 |
| CYP2c9-sub | 0.229 |
| CYP2d6-inh | 0.618 |
| CYP2d6-sub | 0.513 |
| CYP3a4-inh | 0.533 |
| CYP3a4-sub | 0.25 |
| CL | 11.746 |
| T12 | 0.491 |
| hERG | 0.036 |
| Ames | 0.204 |
| ROA | 0.167 |
| SkinSen | 0.06 |
| Carcinogencity | 0.867 |
| EI | 0.011 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.896 |
| Antiviral | Yes |
| Prediction | 0.812883 |